|Bid||2.6600 x 800|
|Ask||2.6900 x 2200|
|Day's range||2.5500 - 2.7400|
|52-week range||1.4050 - 3.4000|
|Beta (5Y monthly)||1.10|
|PE ratio (TTM)||N/A|
|Earnings date||08 May 2023 - 12 May 2023|
|Forward dividend & yield||N/A (N/A)|
|1y target est||4.75|
Ovid Therapeutics ( NASDAQ:OVID ) Full Year 2022 Results Key Financial Results Net loss: US$54.2m (down by 145% from...
If you want to know who really controls Ovid Therapeutics Inc. ( NASDAQ:OVID ), then you'll have to look at the makeup...
Even when a business is losing money, it's possible for shareholders to make money if they buy a good business at the...